Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🙌 It's Here: the Only Stock Screener You'll Ever Need Get Started
Humana profit beats as medical costs ease on slow elective-care rebound
Published Nov 02, 2022 07:01AM ET
Updated Nov 02, 2022 11:27AM ET
© Reuters. FILE PHOTO: Signage for Humana Inc. is pictured at a health facility in Queens, New York City, U.S., November 30, 2021. REUTERS/Andrew Kelly
By Raghav Mahobe and Bhanvi Satija
(Reuters) -Humana Inc beat third-quarter profit estimates on Wednesday, as a sluggish recovery in elective procedures helped the health insurer keep medical costs in check.
Rivals such as UnitedHealth Group Inc (NYSE:UNH) and Elevance Health have also benefited from lower-than-expected medical costs, prompting them to raise their full-year forecasts.
Humana (NYSE:HUM) maintained its recently raised annual adjusted profit forecast of about $25 per share, which is just shy of analysts' expectations of $25.03, according to IBES data from Refinitiv.
Shares of the company rose 1% in early trade.
While raising the forecast in September, Humana cited a lack of COVID-19 "headwind materializing" and lower-than-expected medical cost trends in the company's Medicare Advantage and Medicaid businesses.
Humana expects the favorable medical cost trend to continue into 2023, Chief Financial Officer Susan Diamond said on a post-earnings conference call.
The company posted a quarterly ratio of medical expenses to premiums collected of 85.6%, compared with the average estimate of 85.69% in a Refinitiv poll of seven analysts. A lower ratio indicates a tight rein on the insurer's medical costs.
Humana's guidance to enroll 325,000 to 400,000 Medicare Advantage members next year marks a return to the industry's rate one year ahead of schedule, Stephens analyst Scott Fidel said in a note.
Chief Executive Officer Bruce Broussard said the insurer could probably do a "medium to smaller" deal at this time in the primary care business.
"We've looked at some of the larger transactions out there ... not really convinced that's the right direction for us," Broussard said.
Recent media reports have suggested that Humana is among the top bidders to acquire primary care provider Cano Health Inc.
Humana said its adjusted profit for the third quarter was $6.88 per share, above estimates of $6.28, according to Refinitiv data.
Related Articles
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.